US Patent 11858919 HDAC1,2 inhibitors
Patent 11858919 was granted and assigned to Regenacy Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+21 properties)
Article (+212 characters)
US Patent 11858919 HDAC1,2 inhibitors
Article
Patent abstract
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Charles Blum0
John H. Van Duzer0
Ralph Mazitschek0
Date of Patent
January 2, 2024
0Patent Application Number
172784850
Date Filed
September 25, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11858919 HDAC1,2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
